RHOA and PRKCZ control different aspects of cell motility in pancreatic cancer metastatic clones

Molecular Cancer

Volumn 9, Issue , 2010, Pages

  Peruta, Marco D ^a   Giagulli, Cinzia ^a   Laudanna, Carlo ^a   Scarpa, Aldo ^a   Sorio, Claudio ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN KINASE C ZETA; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; PEPTIDE; PROTEIN KINASE C;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ADHESION; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; CELL MIGRATION; CELL MOTILITY; CELL MOTION; CLONE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; LUNG METASTASIS; MALE; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PANCREAS ADENOCARCINOMA; PROTEIN EXPRESSION; PROTEIN FUNCTION; WESTERN BLOTTING; WOUND HEALING; ANIMAL; CELL CLONE; CELL SHAPE; DRUG EFFECT; ENZYMOLOGY; GENETICS; LUNG TUMOR; METABOLISM; METASTASIS; NUDE MOUSE; PANCREAS TUMOR; PATHOLOGY; TUMOR CELL LINE;

MUS MUSCULUS;

ANIMALS; CELL ADHESION; CELL LINE, TUMOR; CELL MEMBRANE PERMEABILITY; CELL MOVEMENT; CELL SHAPE; CLONE CELLS; LUNG NEOPLASMS; MICE; MICE, NUDE; PANCREATIC NEOPLASMS; PEPTIDES; PROTEIN KINASE C; RHOA GTP-BINDING PROTEIN; WOUND HEALING;

EID: 77951249690     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-9-61     Document Type: Article

References (29)

1. Warshaw AL, Fernandez-del Castillo C. Pancreatic carcinoma. N Engl J Med 1992, 326:455-465.
2. Sahai E, Marshall CJ. RHO-GTPases and cancer. Nat Rev Cancer 2002, 2:133-142. 10.1038/nrc725, 12635176.
3. Laudanna C, Sorio C, Tecchio C, Butcher EC, Bonora A, Bassi C, Scarpa A. Motility analysis of pancreatic adenocarcinoma cells reveals a role for the atypical zeta isoform of protein kinase C in cancer cell movement. Lab Invest 2003, 83:1155-1163. 10.1097/01.LAB.0000081390.92179.F3, 12920244.
4. Soon LL. A discourse on cancer cell chemotaxis: where to from here?. IUBMB Life 2007, 59:60-67. 10.1080/15216540701201033, 17454296.
5. Kitamura N, Iwamura T, Taniguchi S, Yamanari H, Kawano MA, Hollingsworth K, Setoguchi T. High collagenolytic activity in spontaneously highly metastatic variants derived from a human pancreatic cancer cell line (SUIT-2) in nude mice. Clin Exp Metastasis 2000, 18:561-571. 10.1023/A:1011900818419, 11688961.
6. Laudanna C, Mochly-Rosen D, Liron T, Constantin G, Butcher EC. Evidence of zeta protein kinase C involvement in polymorphonuclear neutrophil integrin-dependent adhesion and chemotaxis. J Biol Chem 1998, 273:30306-30315. 10.1074/jbc.273.46.30306, 9804792.
7. Prochiantz A. Messenger proteins: homeoproteins, TAT and others. Curr Opin Cell Biol 2000, 12:400-406. 10.1016/S0955-0674(00)00108-3, 10873818.
8. Bolomini-Vittori M, Montresor A, Giagulli C, Staunton D, Rossi B, Martinello M, Constantin G, Laudanna C. Regulation of conformer-specific activation of the integrin LFA-1 by a chemokine-triggered Rho signaling module. Nat Immunol 2009, 10:185-194. 10.1038/ni.1691, 19136961.
9. Giagulli C, Scarpini E, Ottoboni L, Narumiya S, Butcher EC, Constantin G, Laudanna C. RhoA and zeta PKC control distinct modalities of LFA-1 activation by chemokines: critical role of LFA-1 affinity triggering in lymphocyte in vivo homing. Immunity 2004, 20:25-35. 10.1016/S1074-7613(03)00350-9, 14738762.
10. Sorio C, Capelli P, Lissandrini D, Moore PS, Balzarini P, Falconi M, Zamboni G, Scarpa A. Mucinous cystic carcinoma of the pancreas: a unique cell line and xenograft model of a preinvasive lesion. Virchows Arch 2005, 446:239-245. 10.1007/s00428-004-1167-1, 15688169.
11. Sorio C, Moore PS, Ennas MG, Tecchio C, Bonora A, Sartoris S, Balzarini P, Grigolato P, Scarpa A. A novel cell line and xenograft model of ampulla of Vater adenocarcinoma. Virchows Arch 2004, 444:269-277. 10.1007/s00428-003-0936-6, 14677066.
12. Moore PS, Sipos B, Orlandini S, Sorio C, Real FX, Lemoine NR, Gress T, Bassi C, Kloppel G, Kalthoff H, et al. Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of K-ras, p53, p16 and DPC4/Smad4. Virchows Arch 2001, 439:798-802.
13. Wexler H. Accurate identification of experimental pulmonary metastases. J Natl Cancer Inst 1966, 36:641-645.
14. Pasvolsky R, Grabovsky V, Giagulli C, Shulman Z, Shamri R, Feigelson SW, Laudanna C, Alon R. RhoA is involved in LFA-1 extension triggered by CXCL12 but not in a novel outside-in LFA-1 activation facilitated by CXCL9. J Immunol 2008, 180:2815-2823.
15. Caveggion E, Continolo S, Pixley FJ, Stanley ER, Bowtell DD, Lowell CA, Berton G. Expression and tyrosine phosphorylation of Cbl regulates macrophage chemokinetic and chemotactic movement. J Cell Physiol 2003, 195:276-289. 10.1002/jcp.10236, 12652654.
16. Suen PW, Ilic D, Caveggion E, Berton G, Damsky CH, Lowell CA. Impaired integrin-mediated signal transduction, altered cytoskeletal structure and reduced motility in Hck/Fgr deficient macrophages. J Cell Sci 1999, 112(Pt 22):4067-4078.
17. Bardeesy N, DePinho RA. Pancreatic cancer biology and genetics. Nat Rev Cancer 2002, 2:897-909. 10.1038/nrc949, 12459728.
18. Bourguignon LY, Zhu H, Shao L, Zhu D, Chen YW. Rho-kinase (ROK) promotes CD44v(3,8-10)-ankyrin interaction and tumor cell migration in metastatic breast cancer cells. Cell Motil Cytoskeleton 1999, 43:269-287. 10.1002/(SICI)1097-0169(1999)43:4<269::AID-CM1>3.0.CO;2-5, 10423269.
19. Oshima K, Takeda M, Kuranaga E, Ueda R, Aigaki T, Miura M, Hayashi S. IKK epsilon regulates F actin assembly and interacts with Drosophila IAP1 in cellular morphogenesis. Curr Biol 2006, 16:1531-1537. 10.1016/j.cub.2006.06.032, 16887350.
20. Wheeler AP, Ridley AJ. Why three Rho proteins? RhoA, RhoB, RhoC, and cell motility. Exp Cell Res 2004, 301:43-49. 10.1016/j.yexcr.2004.08.012, 15501444.
21. Ihara K, Muraguchi S, Kato M, Shimizu T, Shirakawa M, Kuroda S, Kaibuchi K, Hakoshima T. Crystal structure of human RhoA in a dominantly active form complexed with a GTP analogue. J Biol Chem 1998, 273:9656-9666. 10.1074/jbc.273.16.9656, 9545299.
22. Shimizu T, Ihara K, Maesaki R, Kuroda S, Kaibuchi K, Hakoshima T. An open conformation of switch I revealed by the crystal structure of a Mg2+-free form of RHOA complexed with GDP. Implications for the GDP/GTP exchange mechanism. J Biol Chem 2000, 275:18311-18317. 10.1074/jbc.M910274199, 10748207.
23. Zhang B, Zheng Y. Regulation of RhoA GTP hydrolysis by the GTPase-activating proteins p190, p50RhoGAP, Bcr, and 3BP-1. Biochemistry 1998, 37:5249-5257. 10.1021/bi9718447, 9548756.
24. Fujita H, Katoh H, Hasegawa H, Yasui H, Aoki J, Yamaguchi Y, Negishi M. Molecular decipherment of Rho effector pathways regulating tight-junction permeability. Biochem J 2000, 346(Pt 3):617-622. 10.1042/0264-6021:3460617, 1220893, 10698687.
25. Hu WH, Johnson H, Shu HB. Activation of NF-kappaB by FADD, Casper, and caspase-8. J Biol Chem 2000, 275:10838-10844. 10.1074/jbc.275.15.10838, 10753878.
26. Kruidering M, Evan GI. Caspase-8 in apoptosis: the beginning of "the end"?. IUBMB Life 2000, 50:85-90.
27. Moreau V, Tatin F, Varon C, Genot E. Actin can reorganize into podosomes in aortic endothelial cells, a process controlled by Cdc42 and RhoA. Mol Cell Biol 2003, 23:6809-6822. 10.1128/MCB.23.19.6809-6822.2003, 193918, 12972601.
28. Coghlan MP, Chou MM, Carpenter CL. Atypical protein kinases Clambda and -zeta associate with the GTP-binding protein Cdc42 and mediate stress fiber loss. Mol Cell Biol 2000, 20:2880-2889. 10.1128/MCB.20.8.2880-2889.2000, 85517, 10733591.
29. Etienne-Manneville S. Actin and microtubules in cell motility: which one is in control?. Traffic 2004, 5:470-477. 10.1111/j.1600-0854.2004.00196.x, 15180824.